An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions

References

1. 1.↵
   1. Ellison DL,
   2. Moran HR

   . Vitamin D: vitamin or hormone? Nurs Clin North Am 2021;56:47–57.

   OpenUrl
2. 2.↵
   1. Wang Y,
   2. Zhu J,
   3. DeLuca HF

   . Where is the vitamin D receptor? Arch Biochem Biophys 2012;523:123–33.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Cashman KD

   . Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int 2020;106:14–29.

   OpenUrlCrossRef
4. 4.↵
   1. Schleicher RL,
   2. Sternberg MR,
   3. Looker AC,
   4. et al

   . National estimates of serum total 25-hydroxy vitamin D and metabolite concentrations measured by liquid chromatography—tandem mass spectrometry in the US population during 2007–2010. J Nutr 2016;146:1051–61.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Holick MF

   . Vitamin D: a D-lightful solution for health. J Investig Med Off Med 2011;59:872–80.

   OpenUrl
6. 6.↵
   National Institutes of Health, Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. Published March 2, 2018. Updated August 12, 2022. Accessed February 9, 2022. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/.
7. 7.↵
   1. Kulie T,
   2. Groff A,
   3. Redmer J,
   4. Hounshell J,
   5. Schrager S

   . Vitamin D: an evidence-based review. J Am Board Fam Med 2009;22:698–706.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Finley CR,
   2. Chan DS,
   3. Garrison S,
   4. et al

   . What are the most common conditions in primary care? Can Fam Physician 2018;64:832–40.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Ahmad FB,
   2. Anderson RN

   . The leading causes of death in the US for 2020. JAMA 2021;325:1829–30.

   OpenUrlPubMed
10. 10.↵
    Food and Drug Administration. Comments to the Proposed Rule and the Supplemental Proposed Rule, Our Responses, and a Description of the Final Rule. Published May 27, 2016. Accessed June 9, 2022. Available from https://www.govinfo.gov/content/pkg/FR-2016-05-27/pdf/2016-11867.pdf.
11. 11.↵
    1. Neale RE,
    2. Baxter C,
    3. Romero BD,
    4. et al

    . The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol 2022;10:120–8.

    OpenUrl
12. 12.↵
    1. Zhang Y,
    2. Fang F,
    3. Tang J,
    4. et al

    . Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ 2019;366:l4673.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Moraes RB,
    2. Friedman G,
    3. Wawrzeniak IC,
    4. et al

    . Vitamin D deficiency is independently associated with mortality among critically ill patients. Clinics 2015;70:326–32.

    OpenUrlPubMed
14. 14.↵
    1. Heath AK,
    2. Kim IY,
    3. Hodge AM,
    4. et al.

    Vitamin D status and mortality: a systematic review of observational studies. IJERPH 2019;16:383.

    OpenUrl
15. 15.↵
    1. Shen H,
    2. Mei Y,
    3. Zhang K,
    4. Xu X

    . The effect of vitamin D supplementation on clinical outcomes for critically ill patients: a systemic review and meta-analysis of randomized clinical trials. Front Nutr 2021;8:664940.

    OpenUrl
16. 16.↵
    1. Wang L,
    2. Song Y,
    3. Manson JE,
    4. et al

    . Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012;5:819–29.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Kunutsor SK,
    2. Apekey TA,
    3. Steur M

    . Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013;28:205–21.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Manson JE,
    2. Cook NR,
    3. Lee IM,
    4. et al

    . Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019;380:33–44.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Barbarawi M,
    2. Kheiri B,
    3. Zayed Y,
    4. et al

    . Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol 2019;4:765–76.

    OpenUrl
20. 20.↵
    1. Arora P,
    2. Song Y,
    3. Dusek J,
    4. et al

    . Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015;131:254–62.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Zhang D,
    2. Cheng C,
    3. Wang Y,
    4. et al

    . Effect of vitamin D on blood pressure and hypertension in the general population: an update meta-analysis of cohort studies and randomized controlled trials. Prev Chronic Dis 2020;17:E03.

    OpenUrlPubMed
22. 22.↵
    1. Alagacone S,
    2. Verga E,
    3. Verdolini R,
    4. Saifullah SM

    . The association between vitamin D deficiency and the risk of resistant hypertension. Clin Exp Hypertens 2020;42:177–80.

    OpenUrl
23. 23.↵
    1. Witham MD,
    2. Ireland S,
    3. Houston JG,
    4. et al

    . Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 2014;63:706–12.

    OpenUrl
24. 24.↵
    1. Choi YJ,
    2. Kim YH,
    3. Cho CH,
    4. et al.

    Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis. World J Gastroenterol 2015;21:8868–77.

    OpenUrl
25. 25.↵
    1. McCullough ML,
    2. Zoltick ES,
    3. Weinstein SJ,
    4. et al

    . Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. J Natl Cancer Inst 2019;111:158–69.

    OpenUrlPubMed
26. 26.↵
    1. Zhang L,
    2. Zou H,
    3. Zhao Y,
    4. et al

    . Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis. BMJ Open 2019;9:e030513.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Bjelakovic G,
    2. Gluud LL,
    3. Nikolova D,
    4. et al

    . Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev 2014;CD007469.
28. 28.↵
    1. Virtanen JK,
    2. Nurmi T,
    3. Aro A,
    4. et al

    . Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial—a randomized controlled trial. Am J Clin Nutr. Published online January 4 2022;nqab419.
29. 29.↵
    1. Dimitrakopoulou VI,
    2. Tsilidis KK,
    3. Haycock PC,
    4. et al

    . Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ 2017;359:j4761.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Zdrenghea MT,
    2. Makrinioti H,
    3. Bagacean C,
    4. Bush A,
    5. Johnston SL,
    6. Stanciu LA

    . Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol 2017;27.
31. 31.↵
    1. Jolliffe DA,
    2. Greiller CL,
    3. Mein CA,
    4. et al

    . Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr 2018;120:891–900.

    OpenUrl
32. 32.↵
    1. Petrelli F,
    2. Luciani A,
    3. Perego G,
    4. Dognini G,
    5. Colombelli PL,
    6. Ghidini A

    . Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol 2021;211:105883.

    OpenUrl
33. 33.↵
    1. Bassatne A,
    2. Basbous M,
    3. Chakhtoura M,
    4. El Zein O,
    5. Rahme M,
    6. El-Hajj Fuleihan G

    . The link between COVID-19 and vitamin D (VIVID): A systematic review and meta-analysis. Metabolism 2021;119:154753.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Teshome A,
    2. Adane A,
    3. Girma B,
    4. Mekonnen ZA

    . The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis. Front Public Health 2021;9:624559.

    OpenUrl
35. 35.↵
    1. Chiodini I,
    2. Gatti D,
    3. Soranna D,
    4. et al

    . Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front Public Health 2021;9:736665.
36. 36.↵
    1. Villasis-Keever MA,
    2. López-Alarcón MG,
    3. Miranda-Novales G,
    4. et al

    . Efficacy and safety of vitamin D supplementation to prevent COVID-19 in frontline healthcare workers. A randomized clinical trial. Arch Med Res 2022;53:423–30.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Martineau AR,
    2. Jolliffe DA,
    3. Hooper RL,
    4. et al

    . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Stroehlein JK,
    2. Wallqvist J,
    3. Iannizzi C,
    4. et al

    . Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;CD015043.
39. 39.↵
    1. Varikasuvu SR,
    2. Thangappazham B,
    3. Vykunta A,
    4. et al

    . COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022;20:907–13.

    OpenUrl
40. 40.↵
    1. Shah K,
    2. Saxena D,
    3. Mavalankar D

    . Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM Mon J Assoc Physicians 2021;114:175–81.

    OpenUrl
41. 41.↵
    1. Thanapluetiwong S,
    2. Chewcharat A,
    3. Takkavatakarn K,
    4. Praditpornsilpa K,
    5. Eiam-Ong S,
    6. Susantitaphong P

    . Vitamin D supplement on prevention of fall and fracture: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020;99:e21506.

    OpenUrl
42. 42.↵
    1. Dhaliwal R,
    2. Aloia JF

    . Effect of vitamin D on falls and physical performance. Endocrinol Metab Clin North Am 2017;46:919–33.

    OpenUrl
43. 43.↵
    1. Ling Y,
    2. Xu F,
    3. Xia X,
    4. et al

    . Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: an updated meta-analysis. Clin Nutr 2021;40:5531–7.

    OpenUrl
44. 44.↵
    1. Sanders KM,
    2. Stuart AL,
    3. Williamson EJ,
    4. et al

    . Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815–22.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Bischoff-Ferrari HA,
    2. Dawson-Hughes B,
    3. Orav EJ,
    4. et al

    . Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 2016;176:175.

    OpenUrl
46. 46.↵
    1. Smith LM,
    2. Gallagher JC,
    3. Suiter C

    . Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial. J Steroid Biochem Mol Biol 2017;173:317–22.

    OpenUrlCrossRefPubMed
47. 47.↵
    1. Balion C,
    2. Griffith LE,
    3. Strifler L,
    4. et al

    . Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology 2012;79:1397–405.

    OpenUrlCrossRefPubMed
48. 48.↵
    1. Yang T,
    2. Wang H,
    3. Xiong Y,
    4. et al

    . Vitamin D supplementation improves cognitive function through reducing oxidative stress regulated by telomere length in older adults with mild cognitive impairment: a 12-month randomized controlled trial. JAD 2020;78:1509–18.

    OpenUrl
49. 49.↵
    1. Goodwill AM,
    2. Szoeke C

    . A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc 2017;65:2161–8.

    OpenUrlCrossRefPubMed
50. 50.↵
    1. Jorde R,
    2. Kubiak J,
    3. Svartberg J,
    4. et al

    . Vitamin D supplementation has no effect on cognitive performance after four months in mid-aged and older subjects. J Neurol Sci 2019;396:165–71.

    OpenUrl
51. 51.↵
    1. Annweiler C,
    2. Dursun E,
    3. Féron F,
    4. et al

    . Vitamin D and cognition in older adults: updated international recommendations. J Intern Med 2015;277:45–57.

    OpenUrlCrossRefPubMed
52. 52.↵
    1. Annweiler C

    . Vitamin D-mentia: Is vitamin D optional or essential for preventing late-life cognitive decline? J Am Geriatr Soc 2017;65:2155–7.

    OpenUrl
53. 53.↵
    1. Casseb GAS,
    2. Kaster MP,
    3. Rodrigues ALS

    . Potential role of vitamin D for the management of depression and anxiety. CNS Drugs 2019;33:619–37.

    OpenUrl
54. 54.↵
    1. Kim SY,
    2. Jeon SW,
    3. Lim WJ,
    4. et al

    . The relationship between serum vitamin D levels, C-reactive protein, and anxiety symptoms. Psychiatry Investig 2020;17:312–9.

    OpenUrl
55. 55.↵
    1. Anglin RES,
    2. Samaan Z,
    3. Walter SD,
    4. McDonald SD

    . Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry J Psychiatry 2013;202:100–7.

    OpenUrl
56. 56.↵
    1. Okereke OI,
    2. Reynolds CF,
    3. Mischoulon D,
    4. et al

    . Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA 2020;324:471–80.

    OpenUrl
57. 57.↵
    1. Jorde R,
    2. Kubiak J

    . No improvement in depressive symptoms by vitamin D supplementation: results from a randomised controlled trial. J Nutr Sci 2018;7:e30.

    OpenUrl
58. 58.↵
    1. Shaffer JA,
    2. Edmondson D,
    3. Wasson LT,
    4. et al

    . Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med 2014;76:190–6.

    OpenUrlCrossRefPubMedWeb of Science
59. 59.↵
    1. Wu Z,
    2. Malihi Z,
    3. Stewart AW,
    4. et al.

    The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr 2018;21:2022–37.

    OpenUrl
60. 60.↵
    1. Ali OME

    . Prevalence of vitamin D deficiency and its relationship with clinical outcomes in patients with fibromyalgia: a systematic review of the literature. SN Compr Clin Med 2022;4:38.

    OpenUrl
61. 61.↵
    1. Helde-Frankling M,
    2. Björkhem-Bergman L

    . Vitamin D in pain management. IJMS 2017;18:2170.

    OpenUrl
62. 62.↵
    1. Straube S,
    2. Derry S,
    3. Straube C,
    4. Moore RA

    . Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2015;CD015043.
63. 63.↵
    1. Yilmaz R,
    2. Salli A,
    3. Cingoz HT,
    4. et al.

    Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency. Int J Rheum Dis 2016;19:1255–62.

    OpenUrl
64. 64.↵
    1. Pagliai G,
    2. Giangrandi I,
    3. Dinu M,
    4. et al.

    Nutritional interventions in the management of fibromyalgia syndrome. Nutrients 2020;12:12092525.

    OpenUrl
65. 65.↵
    1. Ogurtsova K,
    2. da Rocha Fernandes JD,
    3. Huang Y,
    4. et al

    . IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.

    OpenUrlCrossRefPubMed
66. 66.↵
    1. Huang Y,
    2. Cai X,
    3. Mai W,
    4. et al.

    Association between prediabetes and risk of cardiovascular disease and all-cause mortality: systematic review and meta-analysis. BMJ 2016;i5953.
67. 67.↵
    1. Berridge MJ

    . Vitamin D deficiency and diabetes. Biochem J 2017;474:1321–32.

    OpenUrlAbstract/FREE Full Text
68. 68.↵
    1. Narayan KMV,
    2. Boyle JP,
    3. Thompson TJ,
    4. et al.

    Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007;30:1562–6.

    OpenUrlAbstract/FREE Full Text
69. 69.↵
    1. Rafiq S,
    2. Jeppesen P

    . Body mass index, vitamin D, and type 2 diabetes: a systematic review and meta-analysis. Nutrients 2018;10:1182.

    OpenUrl
70. 70.↵
    1. Barbarawi M,
    2. Zayed Y,
    3. Barbarawi O,
    4. et al

    . Effect of vitamin D supplementation on the incidence of diabetes mellitus. J Clin Endocrinol Metab 2020;105:2857–68.

    OpenUrlPubMed
71. 71.↵
    1. Kawahara T,
    2. Suzuki G,
    3. Mizuno S,
    4. et al

    . Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ. 2022;e066222.
72. 72.↵
    1. Hu Z,
    2. Chen J,
    3. Sun X,
    4. et al.

    Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies. Medicine (Baltimore) 2019;98:e14970.

    OpenUrl
73. 73.↵
    1. Palmer DJ

    . Vitamin D and the development of atopic eczema. J Clin Med 2015;4:1036–50.

    OpenUrl
74. 74.↵
    1. Williams H,
    2. Chalmers J

    . Prevention of atopic dermatitis. Acta Derm Venereol 2020;100:adv00166.

    OpenUrl
75. 75.↵
    1. Hattangdi-Haridas SR,
    2. Lanham-New SA,
    3. Wong WHS

    , et al. Vitamin D deficiency and effects of vitamin D supplementation on disease severity in patients with atopic dermatitis: a systematic review and meta-analysis in adults and children. Nutrients 2019;11:1854.

    OpenUrlPubMed
76. 76.↵
    1. Kim MJ,
    2. Kim SN,
    3. Lee YW,
    4. et al.

    Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: a systematic review and meta-analysis. Nutrients 2016;8:789.

    OpenUrl
77. 77.↵
    1. Wang SS,
    2. Hon KL,
    3. Kong AP,
    4. et al

    . Vitamin D deficiency is associated with diagnosis and severity of childhood atopic dermatitis. Pediatr Allergy Immunol 2014;25:30–5.

    OpenUrlCrossRefPubMed
78. 78.↵
    1. Vähävihu K,
    2. Ala-Houhala M,
    3. Peric M,
    4. et al

    . Narrowband ultraviolet B treatment improves Vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010;163:321–8.

    OpenUrlCrossRefPubMedWeb of Science
79. 79.↵
    1. Mangin M,
    2. Sinha R,
    3. Fincher K

    . Inflammation and vitamin D: the infection connection. Inflamm Res Off Res 2014;63:803–19.

    OpenUrl
80. 80.↵
    1. Yepes-Nuñez JJ,
    2. Brożek JL,
    3. Fiocchi A,
    4. et al

    . Vitamin D supplementation in primary allergy prevention: Systematic review of randomized and non-randomized studies. Allergy 2018;73:37–49.

    OpenUrl
81. 81.↵
    1. Kim G,
    2. Bae JH

    . Vitamin D and atopic dermatitis: A systematic review and meta-analysis. Nutrition 2016;32:913–20.

    OpenUrl
82. 82.↵
    1. Raj KAP,
    2. Handa S,
    3. Narang T,
    4. et al.

    Correlation of serum vitamin D levels with severity of pediatric atopic dermatitis and the impact of vitamin D supplementation on treatment outcomes. J Dermatolog Treat 2022;33:1397–400.

    OpenUrl
83. 83.↵
    1. Mansour NO,
    2. Mohamed AA,
    3. Hussein M,
    4. et al

    . The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: A randomized controlled trial. Pharmacol Res Perspect 2020;8:e00679.
84. 84.↵
    1. Kiely ME,
    2. Wagner CL,
    3. Roth DE

    . Vitamin D in pregnancy: Where we are and where we should go. J Steroid Biochem Mol Biol 2020;201:105669.

    OpenUrlPubMed
85. 85.↵
    1. Urrutia RP,
    2. Thorp JM

    . Vitamin D in pregnancy: current concepts. Curr Opin Obstet Gynecol 2012;24:57–64.

    OpenUrlCrossRefPubMed
86. 86.↵
    1. Sharif K,
    2. Sharif Y,
    3. Watad A,
    4. et al

    . Vitamin D, autoimmunity and recurrent pregnancy loss: More than an association. Am J Reprod Immunol N Immunol 2018;80:e12991.

    OpenUrl
87. 87.↵
    1. Ji J,
    2. Zhai H,
    3. Zhou H,
    4. et al.

    The role and mechanism of vitamin D-mediated regulation of treg/Th17 balance in recurrent pregnancy loss. Am J Reprod Immunol N Immunol 2019;81:e13112.

    OpenUrl
88. 88.↵
    1. Tamblyn JA,
    2. Pilarski NSP,
    3. Markland AD,
    4. et al

    . Vitamin D and miscarriage: a systematic review and meta-analysis. Fertil Steril 2022;118:111–22.
89. 89.↵
    1. Mirzakhani H,
    2. Litonjua AA,
    3. McElrath TF,
    4. et al

    . Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 2016;126:4702–15.

    OpenUrl
90. 90.↵
    1. Khaing W,
    2. Vallibhakara SAO,
    3. Tantrakul V,
    4. et al

    . Calcium and vitamin D supplementation for prevention of preeclampsia: a systematic review and network meta-analysis. Nutrients 2017;9:1141.

    OpenUrl
91. 91.↵
    1. Yue CY,
    2. Ying CM

    . Sufficience serum vitamin D before 20 weeks of pregnancy reduces the risk of gestational diabetes mellitus. Nutr Metab (Lond) 2020;17:89.

    OpenUrl
92. 92.↵
    1. Kalok A

    . Maternal serum vitamin D and spontaneous preterm birth. Clin Exp Obstet Gynecol 2020;47:16–20.

    OpenUrl
93. 93.↵
    1. McDonnell SL,
    2. Baggerly KA,
    3. Baggerly CA,
    4. et al

    . Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PloS One 2017;12:e0180483.

    OpenUrl
94. 94.↵
    1. Wagner CL,
    2. Taylor SN,
    3. Dawodu A,
    4. et al.

    Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients 2012;4:208–30.

    OpenUrlCrossRefPubMed
95. 95.↵
    1. Zhao R,
    2. Zhou L,
    3. Wang S,
    4. et al.

    Effect of maternal vitamin D status on risk of adverse birth outcomes: a systematic review and dose-response meta-analysis of observational studies. Eur J Nutr 2022;61:2881–907.

    OpenUrl
96. 96.↵
    1. Qureshi S,
    2. Wilkinson JE

    . Vitamin D supplementation for women during pregnancy. Am Fam Physician 2013;87:314.

    OpenUrl
97. 97.↵
    1. Nørrisgaard PE,
    2. Haubek D,
    3. Kühnisch J,
    4. et al

    . Association of high-dose vitamin D supplementation during pregnancy with the risk of enamel defects in offspring: a 6-year follow-up of a randomized clinical trial. JAMA Pediatr 2019;173:924–930.

    OpenUrl
98. 98.↵
    1. Liu Y,
    2. Ding C,
    3. Xu R,
    4. et al

    . Effects of vitamin D supplementation during pregnancy on offspring health at birth: a meta-analysis of randomized controlled trails. Clin Nutr Edinb Nutr 2022;41:1532–1540.

    OpenUrl
99. 99.↵
    1. Hollis BW,
    2. Wagner CL

    . Substantial vitamin D supplementation is required during the prenatal period to improve birth outcomes. Nutrients 2022;14:899.

    OpenUrl
100. 100.↵
     American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 495: Vitamin D screening and supplementation during pregnancy. Obstet Gynecol 2011;118:197–198.

     OpenUrlCrossRefPubMed
101. 101.↵
     1. Gila-Diaz A,
     2. Arribas SM,
     3. Algara A,
     4. et al

     . A review of bioactive factors in human breastmilk: a focus on prematurity. Nutrients 2019;11:1307.

     OpenUrlCrossRefPubMed
102. 102.↵
     1. Chatterton DEW,
     2. Nguyen DN,
     3. Bering SB,
     4. Sangild PT

     . Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol 2013;45:1730–1747.

     OpenUrlCrossRefPubMed
103. 103.↵
     1. Andreas NJ,
     2. Kampmann B,
     3. Mehring Le-Doare K

     . Human breast milk: a review on its composition and bioactivity. Early Hum Dev 2015;91:629–635.

     OpenUrlCrossRefPubMed
104. 104.↵
     Breastfeeding, Family Physicians Supporting (Position Paper). Published 2001. Updated April 2021. Accessed March 9, 2022. Available from: https://www.aafp.org/about/policies/all/breastfeeding-position-paper.html.
105. 105.↵
     American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 756. Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol 2018;132:e187–e196.

     OpenUrl
106. 106.↵
     1. Wagner CL,
     2. Greer FR

     . Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142–1152.

     OpenUrlCrossRefPubMedWeb of Science
107. 107.↵
     1. O’Callaghan KM,
     2. Taghivand M,
     3. Zuchniak A,
     4. et al

     . Vitamin D in breastfed infants: systematic review of alternatives to daily supplementation. Adv Nutr 2019;nmz098.
108. 108.↵
     1. Tung KTS,
     2. Wong RS,
     3. Tsang HW,
     4. et al

     . An assessment of risk factors for insufficient levels of vitamin D during early Infancy. Nutrients 2021;13:1068.

     OpenUrl
109. 109.↵
     1. Kazemain E,
     2. Ansari S,
     3. Davoodi SH,
     4. et al

     . The effect of maternal vitamin D supplementation on vitamin D status of exclusively breastfeeding mothers and their nursing infants: a systematic review and meta-analysis of randomized clinical trials. Adv Nutr 2021;nmab126.
110. 110.↵
     1. Sen S,
     2. Penfield-Cyr A,
     3. Hollis BW,
     4. Wagner CL

     . Maternal obesity, 25-hydroxy vitamin D concentration, and bone density in breastfeeding dyads. J Pediatr 2017;187:147–152.

     OpenUrl
111. 111.↵
     1. Chalcraft JR,
     2. Cardinal LM,
     3. Wechsler PJ,
     4. et al

     . Vitamin D synthesis following a single bout of sun exposure in older and younger men and women. Nutrients 2020;12:2237.

     OpenUrl
112. 112.↵
     1. Nadeem S,
     2. Munim TF,
     3. Hussain HF,
     4. Hussain DF

     . Determinants of vitamin D deficiency in asymptomatic healthy young medical students. Pak J Med Sci 2018;34:1248–1252.

     OpenUrl
113. 113.↵
     1. Brown LL,
     2. Cohen B,
     3. Tabor D,
     4. et al.

     The vitamin D paradox in Black Americans: a systems-based approach to investigating clinical practice, research, and public health expert panel meeting report. BMC Proc 2018;12:6–6.

     OpenUrl
114. 114.↵
     1. Vavricka SR,
     2. Rogler G

     . Intestinal absorption and vitamin levels: is a new focus needed? Dig Dis 2012;30:73–80.

     OpenUrlCrossRefPubMed
115. 115.↵
     1. Ekwaru JP,
     2. Zwicker JD,
     3. Holick MF,
     4. et al.

     The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxy vitamin D in healthy volunteers. PLoS ONE 2014;9:e111265.

     OpenUrlCrossRef
116. 116.↵
     1. Aarts E,
     2. van Groningen L,
     3. Horst R,
     4. et al

     . Vitamin D absorption: consequences of gastric bypass surgery. Eur J Endocrinol 2011;164:827–832.

     OpenUrlAbstract/FREE Full Text
117. 117.↵
     1. LeFevre ML

     . Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015;162:133–140.

     OpenUrlCrossRefPubMed
118. 118.↵
     1. Burnett-Bowie SAM,
     2. Cappola AR

     . The USPSTF 2021 recommendations on screening for asymptomatic vitamin D deficiency in adults: the challenge for clinicians continues. JAMA 2021;325:1401–1402.

     OpenUrl
119. 119.↵
     1. Pilz S,
     2. Zittermann A,
     3. Trummer C,
     4. et al

     . Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect 2019;8:R27–R43.

     OpenUrlPubMed
120. 120.↵
     1. Parva NR,
     2. Tadepalli S,
     3. Singh P,
     4. et al

     . Prevalence of vitamin D deficiency and associated risk factors in the US population. Cureus 2018;10:e2741.

     OpenUrl
121. 121.
     US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. JAMA 2018;319(16):1696–1704.
122. 122.
     US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement. JAMA 2018;319:1592–1599.

     OpenUrlCrossRefPubMed